QTERNMET
- Product NDC
- 0310-6925
- 11-digit product format
- 003106925
- Labeler code
- 0310
- Product ID
- 0310-6925_19500f2f-6cc0-4c18-ad84-e33206608c10
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dapagliflozin saxagliptin and metformin hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AstraZeneca Pharmaceuticals LP
- Application
- NDA210874
- Marketing category
- NDA
- Marketing start
- 2020-06-01
- Marketing end
- 0000-00-00
- Substance
- DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE; METFORMIN HYDROCHLORIDE
- Active strength
- 3 mg/1; mg/1; mg/1
- Pharmacologic classes
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0310-6925-60 | 00310692560 | 60 TABLET, FILM COATED in 1 BOTTLE (0310-6925-60) | 2020-06-01 | 0000-00-00 | No | No | Current |